semaglutide vs intermittent fasting outperforms traditional drugs in managing early type 2 diabetes Semaglutide and Intermittent Fasting: Safety

prescribing for overweight or obesity was largely off-label, as this indication was not authorized until December 2022

While primarily designed for fat reduction, this treatment simultaneously promotes skin contraction as the body naturally processes frozen fat cells

Some people find that their food preferences and comfort levels shift as their body adapts to semaglutide, so flexibility and open communication with your provider ensure you stay comfortable and compliant with your medication regimen

For more information, call the Cancer Information Service (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237)

[17] The GP may arrange blood tests (including liver function tests, amylase, and lipase) and imaging studies